Company profile
CatalYm company profile
CatalYm is a biotechnology company committed to developing innovative immunotherapies for cancer patients. CatalYm has identified GDF-15 as a central regulator of the immune system in the tumor microenvironment and translates the therapeutic potential of neutralizing GDF-15 into meaningful clinical responses for patients with solid tumors. CatalYm’s CTL-002 program is poised to demonstrate clinical proof-of-concept in multiple solid tumor indications and has the potential to expand the treatment horizon for current and future immunotherapies.
Business identity
- Website
- http://www.catalym.com
- Contact email
- [email protected]
- Phone number
- +49 89 200066440
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2016-01-01
Headquarters
- Headquarters
- Bayern, Germany, Planegg
- Postal code
- 82152
- Country code
- DE
- Continent
- Europe